{"id":11914,"date":"2026-01-14T10:45:26","date_gmt":"2026-01-14T09:45:26","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=11914"},"modified":"2026-03-03T09:36:13","modified_gmt":"2026-03-03T08:36:13","slug":"three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/","title":{"rendered":"Three questions to our new Vice Chair of the Ecosystem Committee (SEC): Bairbre Hickie, General Manager Switzerland Takeda"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/01\/BAIRBRE_HICKIE_DSC8736-2-1024x768.jpg\" alt=\"\" class=\"wp-image-31699\"\/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-competition-between-international-pharmaceutical-locations-is-constantly-increasing-where-do-you-see-the-biggest-differentiating-factors-for-switzerland-as-a-location\"><strong>Competition between international pharmaceutical locations is constantly increasing. Where do you see the biggest differentiating factors for Switzerland as a location?<\/strong>\u00a0<\/h2>\n\n\n\n<p>Reliability and predictability through stable framework conditions are the factors I think of first \u2013 above all thanks to the stability of institutions shaped by Switzerland\u2019s direct-democratic system and the strong role of municipalities and cantons, in close coordination with the federal level. This well-established and pragmatically oriented policy machinery fosters competition, not least in terms of location, and is likely one of Switzerland\u2019s strengths \u2013 though we must ensure it does not become a disadvantage in terms of speed.<\/p>\n\n\n\n<p>Switzerland also benefits from a dense, high-quality talent ecosystem \u2013 world-class universities, the Swiss apprenticeship culture, and a workforce that combines strong domestic capabilities with international expertise that performs exceptionally well in cross-functional settings \u2013 though this advantage is not guaranteed and could come under pressure, e.g., in the context of CH\u2013EU relations.<\/p>\n\n\n\n<p>The Most-Favored-Nation discussion also shows that Switzerland is not an island when it comes to global location competition. I am convinced, however, that Switzerland\u2019s high degree of planning security creates enormous added value \u2013 especially for the pharmaceutical sector, whether in R&amp;D, manufacturing, or commercial operations. Sustained, future-proof investments in Switzerland \u2013 in people as well as in technological advancement \u2013 will continue to ensure strong supply chains to the benefit of patients, not only in Switzerland, but worldwide.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-in-which-area-do-you-see-the-greatest-unused-potential-in-the-swiss-pharmaceutical-ecosystem\"><strong>In which area do you see the greatest unused potential in the Swiss pharmaceutical ecosystem?\u00a0<\/strong><\/h2>\n\n\n\n<p>In my view, despite a solid foundation, there is indeed still clear potential. I see this particularly in a stronger narrative \u2013 and the corresponding strategies \u2013 to further establish Switzerland as a Life Science Hub. The goal should be to align all key stakeholders consistently around Switzerland\u2019s role as a reliable global supply and innovation hub. This, together with the right investment decisions \u2013 based on framework conditions that reduce unnecessary bureaucracy and support European and global interaction as well as progress in digitalization \u2013 will strengthen Switzerland\u2019s location ecosystem and is the logical counterpart to a domestic market that puts patient access first.<\/p>\n\n\n\n<p>Specifically on digitalization, I see a need to upgrade skills to meet next-generation requirements. This includes systematic upskilling for AI-enabled operations in manufacturing and commercial functions, as well as the broader digitalization of the Swiss healthcare system. There is real potential for industry, science, academia, and public authorities to tackle this challenge even more jointly \u2013 potentially also in the spirit of agile, pilot-driven collaboration.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-other-priorities-would-you-like-to-set-in-your-new-role-as-vice-chair-of-the-sec-nbsp\"><strong>What other priorities would you like to set in your new role as Vice Chair of the SEC?<\/strong>&nbsp;<\/h2>\n\n\n\n<p>Ultimately, my aim is to build on the strengths mentioned above \u2013 something that is far from easy in today\u2019s global economic and policy landscape \u2013 while at the same time addressing, in a targeted way, the opportunities also highlighted. By combining speed, simplicity, and predictability, we can achieve this \u2013 and that is exactly what I expect from Switzerland\u2019s framework conditions for our industry.<\/p>\n\n\n\n<p>I look forward to working with the Chair and all members of the Swiss Ecosystem Committee, and I am convinced that we can drive an even stronger \u201cfootprint-first\u201d agenda for the pharmaceutical industry in Switzerland \u2013 one that must be closely linked to market needs and always keeps in mind the needs of patients in the domestic market, including rapid access to innovation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Competition between international pharmaceutical locations is constantly increasing. Where do you see the biggest differentiating factors for Switzerland as a location?\u00a0 Reliability and predictability through stable framework conditions are the factors I think of first \u2013 above all thanks to the stability of institutions shaped by Switzerland\u2019s direct-democratic system and the strong role of municipalities [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3800,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[114,119,129],"class_list":["post-11914","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-research","tag-innovation-en","tag-pharmastandort-2030-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Three questions to our new Vice Chair of the Ecosystem Committee (SEC): Bairbre Hickie, General Manager Switzerland Takeda - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Three questions to our new Vice Chair of the Ecosystem Committee (SEC): Bairbre Hickie, General Manager Switzerland Takeda\" \/>\n<meta property=\"og:description\" content=\"Competition between international pharmaceutical locations is constantly increasing. Where do you see the biggest differentiating factors for Switzerland as a location?\u00a0 Reliability and predictability through stable framework conditions are the factors I think of first \u2013 above all thanks to the stability of institutions shaped by Switzerland\u2019s direct-democratic system and the strong role of municipalities [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-14T09:45:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T08:36:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/01\/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Three questions to our new Vice Chair of the Ecosystem Committee (SEC): Bairbre Hickie, General Manager Switzerland Takeda\",\"datePublished\":\"2026-01-14T09:45:26+00:00\",\"dateModified\":\"2026-03-03T08:36:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/\"},\"wordCount\":578,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/01\/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg\",\"keywords\":[\"Research\",\"Innovation\",\"Pharmastandort 2030\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/\",\"url\":\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/\",\"name\":\"Three questions to our new Vice Chair of the Ecosystem Committee (SEC): Bairbre Hickie, General Manager Switzerland Takeda - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/01\/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg\",\"datePublished\":\"2026-01-14T09:45:26+00:00\",\"dateModified\":\"2026-03-03T08:36:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/01\/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/01\/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg\",\"width\":2560,\"height\":1920},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Three questions to our new Vice Chair of the Ecosystem Committee (SEC): Bairbre Hickie, General Manager Switzerland Takeda\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Three questions to our new Vice Chair of the Ecosystem Committee (SEC): Bairbre Hickie, General Manager Switzerland Takeda - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/","og_locale":"en_US","og_type":"article","og_title":"Three questions to our new Vice Chair of the Ecosystem Committee (SEC): Bairbre Hickie, General Manager Switzerland Takeda","og_description":"Competition between international pharmaceutical locations is constantly increasing. Where do you see the biggest differentiating factors for Switzerland as a location?\u00a0 Reliability and predictability through stable framework conditions are the factors I think of first \u2013 above all thanks to the stability of institutions shaped by Switzerland\u2019s direct-democratic system and the strong role of municipalities [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/","og_site_name":"Interpharma","article_published_time":"2026-01-14T09:45:26+00:00","article_modified_time":"2026-03-03T08:36:13+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/01\/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"Written by":"berta_admin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Three questions to our new Vice Chair of the Ecosystem Committee (SEC): Bairbre Hickie, General Manager Switzerland Takeda","datePublished":"2026-01-14T09:45:26+00:00","dateModified":"2026-03-03T08:36:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/"},"wordCount":578,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/01\/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg","keywords":["Research","Innovation","Pharmastandort 2030"],"inLanguage":"en-US","copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/","url":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/","name":"Three questions to our new Vice Chair of the Ecosystem Committee (SEC): Bairbre Hickie, General Manager Switzerland Takeda - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/01\/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg","datePublished":"2026-01-14T09:45:26+00:00","dateModified":"2026-03-03T08:36:13+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/01\/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/01\/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg","width":2560,"height":1920},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/en\/"},{"@type":"ListItem","position":2,"name":"Three questions to our new Vice Chair of the Ecosystem Committee (SEC): Bairbre Hickie, General Manager Switzerland Takeda"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/11914","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/comments?post=11914"}],"version-history":[{"count":5,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/11914\/revisions"}],"predecessor-version":[{"id":13913,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/11914\/revisions\/13913"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/media\/3800"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/media?parent=11914"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/tags?post=11914"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}